If a patient requires a combination therapy including a beta-lactamase inhibitor, which option would be appropriate from the list?

Get ready for the MDC Pharmacokinetics (PK) II Exam. Study with flashcards and multiple choice questions, each offering hints and explanations. Excel in your exam preparation!

Multiple Choice

If a patient requires a combination therapy including a beta-lactamase inhibitor, which option would be appropriate from the list?

Explanation:
Beta-lactamase inhibitors are added to beta-lactam antibiotics to overcome bacterial resistance by preventing the enzyme from breaking down the drug’s beta-lactam ring. The option that combines amoxicillin with clavulanic acid includes this inhibitor, enabling activity against beta-lactamase–producing organisms. The other choices are antibiotic combinations that do not include a beta-lactamase inhibitor, so they wouldn’t provide protection against beta-lactamase–producing bacteria. Therefore, the amoxicillin-clavulanate combination is the appropriate choice.

Beta-lactamase inhibitors are added to beta-lactam antibiotics to overcome bacterial resistance by preventing the enzyme from breaking down the drug’s beta-lactam ring. The option that combines amoxicillin with clavulanic acid includes this inhibitor, enabling activity against beta-lactamase–producing organisms. The other choices are antibiotic combinations that do not include a beta-lactamase inhibitor, so they wouldn’t provide protection against beta-lactamase–producing bacteria. Therefore, the amoxicillin-clavulanate combination is the appropriate choice.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy